New product development process and time-to-market in the generic pharmaceutical industry

Prašnikar, Janez; Škerlj, Tina

doi:10.1016/j.indmarman.2005.06.001

Cited by 57 publications

(29 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This phase starts with an experimental and accelerated stability study, with development based on a laboratorial scale including the (pilot) bio-equivalent-study and development of primary packaging. A scale-up from the laboratorial to the semi-industrial scale is performed (Cross, 2008;Prašnikar and Škerlj, 2006;Wheelwright, 2010;Witell et al, 2014). However, as shown in Figure 1, this research discovered that this phase itself consists of three parallel paths.…”

Section: The Npd Processmentioning

confidence: 97%

“…A dedicated expert team decides which ideas/candidates should be selected to proceed to the preliminary assessment phase (Akhilesh, 2014;Berber et al, 2013;Poetz and Schreier, 2012;Prašnikar and Škerlj, 2006;Urbig et al, 2013;Witell et al, 2011;Yan and Kull, 2014).…”

Section: The Npd Processmentioning

confidence: 99%

“…This is the rough assessment of the API candidates, resulting from a desk research or brainstorming meeting with NPD specialists in the areas of product design, operations, R&D, marketing, sales, and after sale service (Boonkanit et al, 2010;Prašnikar and Škerlj, 2006;Sun and Wing, 2005;Witell et al, 2014).…”

Section: The Npd Processmentioning

confidence: 99%

See 2 more Smart Citations

NPD process in active pharmaceutical ingredients industry: a case study in Iran

Shahmehr

Khaksar

Safari

et al. 2017

IJBIR

View full text Add to dashboard Cite

Due to recent sanctions against Iran, the Iranian active pharmaceutical ingredients (APIs) industry has become increasingly scrutinised. However, innovation and new product development (NPD) are challenges for Iranian APIs; especially as in the domestic market they face substantial competition from Asian and American competitors. This paper investigates the existing NPD situation in the APIs industry in Iran. To do so, the researchers have explored the extent to which the APIs industry follows an innovation strategy or imitation strategy by discovering factories influencing the NPD process. This paper also includes a case-study on the APIs industry in Taamin Active Pharmaceutical Ingredient Company (TAPIC) holding. A wide variety of data collection methods were used, ranging from semi-structured questionnaire and interviews, literature reviews, archival record analysis and participant observation. The findings show that "possessing skilled and professional teams" is the most important activity for designing a successful NPD process in APIs. In contrast, "high cost of importing new technologies" tends to be the main restriction that endangers a successful NPD process in APIs in Iran.

show abstract

Section: The Npd Processmentioning

confidence: 97%

Section: The Npd Processmentioning

confidence: 99%

See 1 more Smart Citation

NPD process in active pharmaceutical ingredients industry: a case study in Iran

Shahmehr

Khaksar

Safari

et al. 2017

IJBIR

View full text Add to dashboard Cite

show abstract

“…Therefore, it is important to extract effective variables associated with product development to improve performance measurement of firms. Prašnikar and Škerlj (2006) investigated the organizational and managerial factors lying behind time-to-market in four firms in Central and Eastern Europe. They presented some factors incorporated into a diagnostic framework of new product development in generic pharmaceutical companies.…”

Section: Introductionmentioning

confidence: 99%

Investigating product development strategy in beverage industry using factor analysis

Azad¹,

Aliakbar²,

Zarifi³

et al. 2013

msl

View full text Add to dashboard Cite

Selecting a product development strategy that is associated with the company's current service or product innovation, based on customers' needs and changing environment, plays an important role in increasing demand, increasing market share, increasing sales and profits. Therefore, it is important to extract effective variables associated with product development to improve performance measurement of firms. This paper investigates important factors influencing product development strategies using factor analysis. The proposed model of this paper investigates 36 factors and, using factor analysis, we extract six most influential factors including information sharing, intelligence information, exposure strategy, differentiation, research and development strategy and market survey.The first strategy, partnership, includes five sub-factor including product development partnership, partnership with foreign firms, customers' perception from competitors' products, Customer involvement in product development, inter-agency coordination, customer-oriented approach to innovation and transmission of product development change where inter-agency coordination has been considered the most important factor. Internal strengths are the most influential factors impacting the second strategy, intelligence information. The third factor, introducing strategy, introducing strategy, includes four sub criteria and consumer buying behavior is the most influencing factor. Differentiation is the next important factor with five components where knowledge and expertise in product innovation is the most important one. Research and development strategy with four sub-criteria where reducing product development cycle plays the most influential factor and finally, market survey strategy is the last important factor with three factors and finding new market plays the most important role.

show abstract

“…Five years are generally consumed in a generic drug development. Especially, a laboratory development phase consumes around 25% from the entire development cycle [1]. Time consuming in a laboratory development phase is caused by implicit details in an original drug patent.…”

Section: Introductionmentioning

confidence: 99%

A Framework of Ontology-Based Tablet Production Supporting System for a Drug Reformulation

Chalortham

Leesawat

Ruangrajitpakorn

et al. 2011

IEICE Trans. Inf. & Syst.

View full text Add to dashboard Cite

SUMMARYThis paper presents a framework of supporting system for a drug formulation. We designed ontology to represent the related knowledge for reusable and sharing purposes. The designed ontology is applied with operation rules to suggest an appropriate generic drug production based on information of original drug. The system also provides a validation module to preliminarily approve a pharmaceutical equivalence of the suggested result. Preliminary testing with four random samples shows potential to reformulate a generic product by returning a satisfactory and acceptable of the system suggestions for all samples.

show abstract

New product development process and time-to-market in the generic pharmaceutical industry

Cited by 57 publications

References 34 publications

NPD process in active pharmaceutical ingredients industry: a case study in Iran

NPD process in active pharmaceutical ingredients industry: a case study in Iran

Investigating product development strategy in beverage industry using factor analysis

A Framework of Ontology-Based Tablet Production Supporting System for a Drug Reformulation

Contact Info

Product

Resources

About